MedTrace Logo

Nebulized Dexmedetomidine, Ketamine, or Midazolam in Children Undergoing Adenotonsillectomy

NCT07564037 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-05-07

No results posted yet for this study

Summary

The aim of this study is to compare between nebulized dexmedetomidine, ketamine, or midazolam for premedication in children undergoing adenotonsillectomy.

Conditions

  • Dexmedetomidine
  • Adenotonsillectomy
  • Midazolam
  • Children

Interventions

DRUG

Group K:nebulized ketamine group

Patients will receive nebulized ketamine 2 mg kg -1

DRUG

Group D:dexmedetomidine group

Patients will receive dexmedetomidine 2 mcg kg -1

DRUG

Group M: midazolam group

Patients will receive midazolam 0.2 mg kg -1

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-30
Primary Completion
2025-11-30
Completion
2025-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07564037 on ClinicalTrials.gov